Brian Wong

CEO
Biotechnology
FLX Bio
United States of America

Biography

Brian joined FLX Bio in 2015 from Five Prime Therapeutics, where he served as Senior Vice President, Research, and Head of Immuno-Oncology. At Five Prime, he led the discovery of novel immuno-oncology therapeutics, one of which has progressed to clinical trials in combination with Bristol-Myers Squibb Co.'s (BMS) Opdivo™. BMS has pledged more than $1 billion to exclusively license the program.

Research Interest

Biotechnology

Global Experts from United States of America

Global Experts in Subject

Share This Profile

Recent Expert Updates

Matthew L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. Matthew
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. L Stone Matthew
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. Matthew L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. R Sameh
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Sameh R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. Sameh R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. William
pediatrics
Maimonides Medical Center
United States of America